SILVER SPRING, Md.,
May 23, 2013 /PRNewswire/ --
Pharmagen, Inc. (OTCBB: PHRX) (the "Company" or "Pharmagen")
announced today that Mackie A.
Barch, CEO, will present at the Second Annual Marcum LLP
MicroCap Conference on Thursday, May 30,
2013 in New York City at
the Grand Hyatt Hotel.
The Company's presentation is scheduled to begin at 2:30 p.m. EDT and will be available via a live
webcast.
For more information and registration, please visit the
conference website: http://www.marcumllp.com/microcap
About Pharmagen
Pharmagen, Inc. ("Pharmagen"), and wholly owned subsidiaries and
operating divisions Pharmagen Laboratories, Inc., Pharmagen
Distribution, LLC and Pharmagen Nutraceuticals, Inc. is the leader
in innovative solutions to the nations sterile pharmaceutical
crisis. With a multifaceted approach, Pharmagen is meeting the
demand of health provider market through dynamic, independent
wholesale, compounding, and innovative IT solutions.
Nationally focused, Pharmagen is a dynamic distributor of specialty
drugs, compounding and admix pharmacy and producer of
over-the-counter ("OTC") branded multivitamins to the healthcare
provider market. Pharmagen currently functions as a just-in-time
source of supply for hospitals for those products that are
hard-to-find due to drug manufacturers' production shortages.
About Marcum LLP
Marcum LLP is one of the largest independent public accounting
and advisory services firms in the nation. Ranked among the top 15,
Marcum LLP offers the resources of 1,000 professionals, including
over 125 partners, in more than 20 offices throughout New York, New
Jersey, Massachusetts,
Connecticut, Pennsylvania, California, Florida, Grand
Cayman and China.
Headquartered in New York City,
the Firm's presence runs deep with full-service offices
strategically located in major business markets. Marcum is a member
of the Marcum Group, an organization providing a comprehensive
range of professional services spanning accounting and advisory,
technology solutions, wealth management, and executive and
professional recruiting. The Marcum Group companies include Marcum
LLP; Marcum Technology LLC; Marcum Search LLC; Marcum Financial
Services LLC; Marcum Bernstein & Pinchuk LLP; MarcumBuchanan
Associates LLC; and Marcum Cronus Partners LLC.
Contact: 888-264-4597 or info@pharmagenrx.com
Safe Harbor Statement
Information in this document constitute forward-looking
statements or statements which may be deemed or construed to be
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The words "forecast",
"anticipate", "estimate", "project", "intend", "expect", "should",
"believe", and similar expressions are intended to identify
forward-looking statements. These forward-looking statements
involve, and are subject to known and unknown risks, uncertainties
and other factors which could cause Pharmagen actual results,
performance (financial or operating) or achievements to differ from
the future results, performance (financial or operating) or
achievements expressed or implied by such forward-looking
statements. The risks, uncertainties and other factors are more
fully discussed in Pharmagen' filings with the U.S. Securities and
Exchange Commission. All forward-looking statements attributable to
Pharmagen herein are expressly qualified in their entirety by the
above-mentioned cautionary statement. Pharmagen disclaims any
obligation to update forward-looking statements contained in this
estimate, except as may be required by law.
SOURCE Pharmagen, Inc.